Table 2.

Responses to pembrolizumab or placebo treatment

	Pembrolizumab (n = 19)	Placebo (n = 7)
Objective response†	3 (15.8%)	0 (0%)
Disease control rate‡	7 (36.8%)	2 (28.6%)
Best overall response
Complete response	0 (0%)	0 (0%)
Partial response	3 (15.8%)	0 (0%)
Stable disease	4 (21.1%)	2 (28.6%)
Progressive disease	12 (63.2%)	5 (71.4%)

^†Includes complete response and partial response

^‡ Includes complete response, partial response, and stable disease